Enovis ENOV
NYSE ENOV
$26.06 -0.12 (-0.46%)
At close: Aug 21, 2026 · 4:00 PM EDT

Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026)

Enovis (ENOV) posted quarterly Depreciation & Amortization (CF) of $73.4 million for Q2 2026, up 2.69% year-over-year from $71.4 million in Q2 2025, and down 4.75% quarter-over-quarter from $77.0 million in Q4 2025.

Enovis (ENOV) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

Enovis (ENOV) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $73.4 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Depreciation & Amortization (CF) rose 2.69% year-over-year to $73.4 million; the TTM figure through Apr 2026 stood at $296.3 million (up 4.76% YoY), while the FY2025 annual figure was $294.4 million, up 3.36% from the prior year.
  • Depreciation & Amortization (CF) slipped to $73.4 million in Q2 2026 per ENOV's latest filing, from $77.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $97.4 million in Q2 2023 and bottomed at $7.6 million in Q1 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $64.1 million across 5 years, with a median of $71.2 million in 2024.
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) plunged 88.48% — and 2024, when it surged 865.08%.
  • Enovis' Depreciation & Amortization (CF) stood at $52.3 million in 2022, then grew by 8.34% to $56.6 million in 2023, then jumped by 31.42% to $74.4 million in 2024, then climbed by 3.51% to $77.0 million in 2025, then decreased by 4.75% to $73.4 million in 2026.
  • Business Quant data shows ENOV's Depreciation & Amortization (CF) at $73.4 million in Q2 2026, $77.0 million in Q4 2025, and $74.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 355.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 42.70 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 68.20 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 750.89 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 123.80 Mn
10 Enovis 1.51 Bn 1.50 Bn 359.25 Mn 71.03 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 71.03 Mn
Jul 3, 2026 71.03 Mn
Apr 3, 2026 73.36 Mn
Apr 3, 2026 73.36 Mn
Dec 31, 2025 77.01 Mn
Dec 31, 2025 77.01 Mn
Oct 3, 2025 74.38 Mn
Oct 3, 2025 74.38 Mn
Jul 4, 2025 71.55 Mn
Jul 4, 2025 71.55 Mn
Apr 4, 2025 71.44 Mn
Apr 4, 2025 71.44 Mn
Dec 31, 2024 74.40 Mn
Dec 31, 2024 74.40 Mn
Sep 27, 2024 71.23 Mn
Sep 27, 2024 71.23 Mn
Jun 28, 2024 65.76 Mn
Jun 28, 2024 65.76 Mn
Mar 29, 2024 73.40 Mn
Mar 29, 2024 73.40 Mn